TY - JOUR
T1 - Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis
AU - Schröder, Torsten
AU - Kucharczyk, David
AU - Bär, Florian
AU - Pagel, René
AU - Derer, Stefanie
AU - Jendrek, Sebastian Torben
AU - Sünderhauf, Annika
AU - Brethack, Ann Kathrin
AU - Hirose, Misa
AU - Möller, Steffen
AU - Künstner, Axel
AU - Bischof, Julia
AU - Weyers, Imke
AU - Heeren, Jörg
AU - Koczan, Dirk
AU - Schmid, Sebastian Michael
AU - Divanovic, Senad
AU - Giles, Daniel Aaron
AU - Adamski, Jerzy
AU - Fellermann, Klaus
AU - Lehnert, Hendrik
AU - Köhl, Jörg
AU - Ibrahim, Saleh
AU - Sina, Christian
N1 - Funding Information:
This work was supported by the DFG-funded International Research Training Group 1911. We are very grateful for fruitful discussions with Jens Mittag, Department of Medicine I, University of Lübeck. The study was in part supported by the Deutsche Forschungsgemeinschaft (DFG) by a grant to Jörg Heeren ( SFB 841 ). We are also very thankful for the excellent technical assistance of Petra Langstrassen, Heidi Schlichting, and Sandra Ehret. We thank Dr. Cornelia Prehn, Dr. Werner Römisch-Margl, Julia Scarpa and Katharina Faschinger for support with the metabolomics measurements performed at the Helmholtz Centrum München, Genome Analysis Center, Metabolomics Core Facility.
Publisher Copyright:
© 2016 The Authors.
PY - 2016/4/1
Y1 - 2016/4/1
N2 - Objective: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and is associated with an enhanced risk for liver and cardiovascular diseases and mortality. NAFLD can progress from simple hepatic steatosis to non-alcoholic steatohepatitis (NASH). However, the mechanisms predisposing to this progression remain undefined. Notably, hepatic mitochondrial dysfunction is a common finding in patients with NASH. Due to a lack of appropriate experimental animal models, it has not been evaluated whether this mitochondrial dysfunction plays a causative role for the development of NASH. Methods: To determine the effect of a well-defined mitochondrial dysfunction on liver physiology at baseline and during dietary challenge, C57BL/6J-mtFVB/N mice were employed. This conplastic inbred strain has been previously reported to exhibit decreased mitochondrial respiration likely linked to a non-synonymous gene variation (nt7778 G/T) of the mitochondrial ATP synthase protein 8 (mt-ATP8). Results: At baseline conditions, C57BL/6J-mtFVB/N mice displayed hepatic mitochondrial dysfunction characterized by decreased ATP production and increased formation of reactive oxygen species (ROS). Moreover, genes affecting lipid metabolism were differentially expressed, hepatic triglyceride and cholesterol levels were changed in these animals, and various acyl-carnitines were altered, pointing towards an impaired mitochondrial carnitine shuttle. However, over a period of twelve months, no spontaneous hepatic steatosis or inflammation was observed. On the other hand, upon dietary challenge with either a methionine and choline deficient diet or a western-style diet, C57BL/6J-mtFVB/N mice developed aggravated steatohepatitis as characterized by lipid accumulation, ballooning of hepatocytes and infiltration of immune cells. Conclusions: We observed distinct metabolic alterations in mice with a mitochondrial polymorphism associated hepatic mitochondrial dysfunction. However, a second hit, such as dietary stress, was required to cause hepatic steatosis and inflammation. This study suggests a causative role of hepatic mitochondrial dysfunction in the development of experimental NASH.
AB - Objective: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and is associated with an enhanced risk for liver and cardiovascular diseases and mortality. NAFLD can progress from simple hepatic steatosis to non-alcoholic steatohepatitis (NASH). However, the mechanisms predisposing to this progression remain undefined. Notably, hepatic mitochondrial dysfunction is a common finding in patients with NASH. Due to a lack of appropriate experimental animal models, it has not been evaluated whether this mitochondrial dysfunction plays a causative role for the development of NASH. Methods: To determine the effect of a well-defined mitochondrial dysfunction on liver physiology at baseline and during dietary challenge, C57BL/6J-mtFVB/N mice were employed. This conplastic inbred strain has been previously reported to exhibit decreased mitochondrial respiration likely linked to a non-synonymous gene variation (nt7778 G/T) of the mitochondrial ATP synthase protein 8 (mt-ATP8). Results: At baseline conditions, C57BL/6J-mtFVB/N mice displayed hepatic mitochondrial dysfunction characterized by decreased ATP production and increased formation of reactive oxygen species (ROS). Moreover, genes affecting lipid metabolism were differentially expressed, hepatic triglyceride and cholesterol levels were changed in these animals, and various acyl-carnitines were altered, pointing towards an impaired mitochondrial carnitine shuttle. However, over a period of twelve months, no spontaneous hepatic steatosis or inflammation was observed. On the other hand, upon dietary challenge with either a methionine and choline deficient diet or a western-style diet, C57BL/6J-mtFVB/N mice developed aggravated steatohepatitis as characterized by lipid accumulation, ballooning of hepatocytes and infiltration of immune cells. Conclusions: We observed distinct metabolic alterations in mice with a mitochondrial polymorphism associated hepatic mitochondrial dysfunction. However, a second hit, such as dietary stress, was required to cause hepatic steatosis and inflammation. This study suggests a causative role of hepatic mitochondrial dysfunction in the development of experimental NASH.
KW - Lipid metabolism
KW - Mitochondrial dysfunction
KW - Mitochondrial gene polymorphism
KW - NAFLD
KW - Steatohepatitis
KW - TNFα
UR - http://www.scopus.com/inward/record.url?scp=84961837426&partnerID=8YFLogxK
U2 - 10.1016/j.molmet.2016.01.010
DO - 10.1016/j.molmet.2016.01.010
M3 - Article
AN - SCOPUS:84961837426
SN - 2212-8778
VL - 5
SP - 283
EP - 295
JO - Molecular Metabolism
JF - Molecular Metabolism
IS - 4
ER -